Veradermics, Incorporated (MANE)
NYSE
Closed
Oct 22, 2026
Day's Range
136.4352 wk Range
32.00Overview - MANE - Veradermics, Incorporated
Key Statistics
Valuation
Enterprise Value
4.05B
P/E (Trailing)
-45.84
P/E (Forward)
-43.45
PEG Ratio
2.20
Price / Book
5.99
EV / EBITDA
-57.98
Profitability
Profit Margin
0.00%
Operating Margin
0.00%
Return on Assets
-54.62%
Return on Equity
68.89%
Ownership
Shares Outstanding
41.78M
Float
32.29M
Short % of Shares Outstanding
15.09%
Held by Insiders
2.48%
Held by Institutions
98.34%
Price stats
50-Day Avg
107.40
200-Day Avg
89.86
Analyst Consensus
7 analysts
Average price target
$ 164.83Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MANE - Veradermics, Incorporated
Peers - MANE - Veradermics, Incorporated
Peer Comparison
Compared with companies in Biotechnology listed on NYSE.
- MANENYSEVeradermics, Incorporated4.55BMarket Cap+65.35%52-week change-45.84P/E (Trailing)0.00%Profit Margin
- BIONYSEBio-Rad Laboratories Inc.9.45BMarket Cap+8.99%52-week change44.83P/E (Trailing)8.58%Profit Margin
- BSTNYSEBlackRock Science and Technology Trust1.76BMarket Cap+21.83%52-week change7.02P/E (Trailing)0.00%Profit Margin
- BHVNNYSEBiohaven Ltd.1.71BMarket Cap-56.21%52-week change-1.66P/E (Trailing)0.00%Profit Margin
- BCXNYSEBlackRock Resources & Commodities Strategy Trust991.85MMarket Cap+22.29%52-week change4.66P/E (Trailing)0.00%Profit Margin
- ANRONYSEAlto Neuroscience Inc.895.50MMarket Cap+52.45%52-week change-10.42P/E (Trailing)0.00%Profit Margin
- ATTONYSEAttovia Therapeutics Inc.634.09MMarket Cap-57.67%52-week change-5.85P/E (Trailing)0.00%Profit Margin
Profile Summary - MANE - Veradermics, Incorporated
About
Veradermics, Incorporated is a late clinical-stage biopharmaceutical company focused on developing dermatology and aesthetic treatments. Its current pipeline centers on therapies for pattern hair loss, including VDPHL01, an oral, non-hormonal, extended-release minoxidil formulation designed for men and women. The…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
